Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Moreau

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab MonotherapyEmanuele Zucca, Annarita Conconi, Giovanni Martinelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulationFrançois Le Loarer, Arjen H G Cleven, Corinne Bouvier, et al.
The Lancet. Haematology|December 15, 2016
Consolidation anti-CD22 fractionated radioimmunotherapy with <sup>90</sup>Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trialFrançoise Kraeber-Bodere, Amandine Pallardy, Hervé Maisonneuve, et al.
Blood|November 28, 2019
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCLCamille Laurent, Alina Nicolae, Cécile Laurent, et al.
Haematologica|April 4, 2020
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life studySophie Vantyghem, Pierre Peterlin, Sylvain Thépot, et al.
Haematologica|September 2, 2018
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphomaRémy Gressin, Nicolas Daguindau, Adrian Tempescul, et al.
Nature Genetics|December 14, 2021
Discovery of a genetic module essential for assigning left-right asymmetry in humans and ancestral vertebratesEmmanuelle Szenker-Ravi, Tim Ott, Muznah Khatoo, et al.
Nature Genetics|March 19, 2022
Publisher Correction: Discovery of a genetic module essential for assigning left-right asymmetry in humans and ancestral vertebratesEmmanuelle Szenker-Ravi, Tim Ott, Muznah Khatoo, et al.
Nature Genetics|October 6, 2015
MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebratesAnne Guimier, George C Gabriel, Fanny Bajolle, et al.
Cell Reports. Medicine|March 4, 2022
Genetic resiliency associated with dominant lethal <i>TPM1</i> mutation causing atrial septal defect with high heritabilityPolakit Teekakirikul, Wenjuan Zhu, Xinxiu Xu, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab MonotherapyEmanuele Zucca, Annarita Conconi, Giovanni Martinelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulationFrançois Le Loarer, Arjen H G Cleven, Corinne Bouvier, et al.
The Lancet. Haematology|December 15, 2016
Consolidation anti-CD22 fractionated radioimmunotherapy with <sup>90</sup>Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trialFrançoise Kraeber-Bodere, Amandine Pallardy, Hervé Maisonneuve, et al.
Blood|November 28, 2019
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCLCamille Laurent, Alina Nicolae, Cécile Laurent, et al.
Haematologica|April 4, 2020
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life studySophie Vantyghem, Pierre Peterlin, Sylvain Thépot, et al.
Haematologica|September 2, 2018
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphomaRémy Gressin, Nicolas Daguindau, Adrian Tempescul, et al.
Nature Genetics|December 14, 2021
Discovery of a genetic module essential for assigning left-right asymmetry in humans and ancestral vertebratesEmmanuelle Szenker-Ravi, Tim Ott, Muznah Khatoo, et al.
Nature Genetics|March 19, 2022
Publisher Correction: Discovery of a genetic module essential for assigning left-right asymmetry in humans and ancestral vertebratesEmmanuelle Szenker-Ravi, Tim Ott, Muznah Khatoo, et al.
Nature Genetics|October 6, 2015
MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebratesAnne Guimier, George C Gabriel, Fanny Bajolle, et al.
Cell Reports. Medicine|March 4, 2022
Genetic resiliency associated with dominant lethal <i>TPM1</i> mutation causing atrial septal defect with high heritabilityPolakit Teekakirikul, Wenjuan Zhu, Xinxiu Xu, et al.
Pageof 16